Invention Grant
US09029338B2 Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
有权
脂质配制的组合物和抑制基因从埃博拉病毒表达的方法
- Patent Title: Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus
- Patent Title (中): 脂质配制的组合物和抑制基因从埃博拉病毒表达的方法
-
Application No.: US13390095Application Date: 2010-08-13
-
Publication No.: US09029338B2Publication Date: 2015-05-12
- Inventor: Antonin de Fougerolles , Anna Borodovsky , Tatiana Novobrantseva
- Applicant: Antonin de Fougerolles , Anna Borodovsky , Tatiana Novobrantseva
- Applicant Address: US MA Cambridge
- Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Fenwick & West LLP
- International Application: PCT/US2010/045478 WO 20100813
- International Announcement: WO2011/020023 WO 20110217
- Main IPC: A01N43/04
- IPC: A01N43/04 ; C07H21/02 ; A61K48/00
Abstract:
The invention relates to lipid formulated double-stranded ribonucleic acid (dsRNA) for inhibiting the expression of a gene from the Ebola virus.
Public/Granted literature
- US20120270921A1 Lipid Formulated Compositions and Methods for Inhibiting Expression of a Gene from the Ebola Virus Public/Granted day:2012-10-25
Information query
IPC分类:
